• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于多参数磁共振成像的前列腺导管内癌与前列腺腺癌鉴别列线图模型。

Nomogram Models for Distinguishing Intraductal Carcinoma of the Prostate From Prostatic Acinar Adenocarcinoma Based on Multiparametric Magnetic Resonance Imaging.

机构信息

Department of Radiology, West China Hospital, Sichuan University, Sichuan, China.

Department of Pathology, West China Hospital, Sichuan University, Sichuan, China.

出版信息

Korean J Radiol. 2023 Jul;24(7):668-680. doi: 10.3348/kjr.2022.1022.

DOI:10.3348/kjr.2022.1022
PMID:37404109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10323418/
Abstract

OBJECTIVE

To compare multiparametric magnetic resonance imaging (MRI) features of intraductal carcinoma of the prostate (IDC-P) with those of prostatic acinar adenocarcinoma (PAC) and develop prediction models to distinguish IDC-P from PAC and IDC-P with a high proportion (IDC ≥ 10%, hpIDC-P) from IDC-P with a low proportion (IDC < 10%, lpIDC-P) and PAC.

MATERIALS AND METHODS

One hundred and six patients with hpIDC-P, 105 with lpIDC-P and 168 with PAC, who underwent pretreatment multiparametric MRI between January 2015 and December 2020 were included in this study. Imaging parameters, including invasiveness and metastasis, were evaluated and compared between the PAC and IDC-P groups as well as between the hpIDC-P and lpIDC-P subgroups. Nomograms for distinguishing IDC-P from PAC, and hpIDC-P from lpIDC-P and PAC, were made using multivariable logistic regression analysis. The discrimination performance of the models was assessed using the receiver operating characteristic area under the curve (ROC-AUC) in the sample, where the models were derived from without an independent validation sample.

RESULTS

The tumor diameter was larger and invasive and metastatic features were more common in the IDC-P than in the PAC group ( < 0.001). The distribution of extraprostatic extension (EPE) and pelvic lymphadenopathy was even greater, and the apparent diffusion coefficient (ADC) ratio was lower in the hpIDC-P than in the lpIDC-P group ( < 0.05). The ROC-AUCs of the stepwise models based solely on imaging features for distinguishing IDC-P from PAC and hpIDC-P from lpIDC-P and PAC were 0.797 (95% confidence interval, 0.750-0.843) and 0.777 (0.727-0.827), respectively.

CONCLUSION

IDC-P was more likely to be larger, more invasive, and more metastatic, with obviously restricted diffusion. EPE, pelvic lymphadenopathy, and a lower ADC ratio were more likely to occur in hpIDC-P, and were also the most useful variables in both nomograms for predicting IDC-P and hpIDC-P.

摘要

目的

比较前列腺导管内癌(IDC-P)与前列腺腺癌(PAC)的多参数磁共振成像(MRI)特征,建立预测模型,以区分 IDC-P 与 PAC,并区分高比例 IDC-P(IDC≥10%,hpIDC-P)与低比例 IDC-P(IDC<10%,lpIDC-P)和 PAC。

材料与方法

本研究纳入了 2015 年 1 月至 2020 年 12 月期间接受术前多参数 MRI 检查的 106 例 hpIDC-P、105 例 lpIDC-P 和 168 例 PAC 患者。评估并比较了 PAC 与 IDC-P 组以及 hpIDC-P 与 lpIDC-P 亚组之间的侵袭性和转移相关的影像学参数。使用多变量逻辑回归分析建立了鉴别 IDC-P 与 PAC、hpIDC-P 与 lpIDC-P 和 PAC 的列线图。使用样本中的接收者操作特征曲线(ROC-AUC)评估模型的鉴别性能,模型在没有独立验证样本的情况下得出。

结果

与 PAC 组相比,IDC-P 组的肿瘤直径更大,侵袭性和转移性特征更常见(<0.001)。HPIDC-P 组的前列腺外延伸(EPE)和盆腔淋巴结病变分布更为广泛,表观扩散系数(ADC)比值更低(<0.05)。仅基于影像学特征的逐步模型用于鉴别 IDC-P 与 PAC 以及 hpIDC-P 与 lpIDC-P 和 PAC 的 ROC-AUC 分别为 0.797(95%置信区间,0.750-0.843)和 0.777(0.727-0.827)。

结论

IDC-P 更有可能体积更大、侵袭性更强、转移性更高,扩散受限明显。HPIDC-P 更有可能出现 EPE、盆腔淋巴结病变和 ADC 比值较低,这也是两个列线图预测 IDC-P 和 hpIDC-P 中最有用的变量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c9/10323418/8fe74d1a2255/kjr-24-668-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c9/10323418/4ad169766f89/kjr-24-668-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c9/10323418/402c8625549f/kjr-24-668-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c9/10323418/713cebbc8be4/kjr-24-668-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c9/10323418/74fc9e4e0805/kjr-24-668-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c9/10323418/7b6689bab7cd/kjr-24-668-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c9/10323418/8fe74d1a2255/kjr-24-668-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c9/10323418/4ad169766f89/kjr-24-668-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c9/10323418/402c8625549f/kjr-24-668-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c9/10323418/713cebbc8be4/kjr-24-668-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c9/10323418/74fc9e4e0805/kjr-24-668-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c9/10323418/7b6689bab7cd/kjr-24-668-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c9/10323418/8fe74d1a2255/kjr-24-668-g006.jpg

相似文献

1
Nomogram Models for Distinguishing Intraductal Carcinoma of the Prostate From Prostatic Acinar Adenocarcinoma Based on Multiparametric Magnetic Resonance Imaging.基于多参数磁共振成像的前列腺导管内癌与前列腺腺癌鉴别列线图模型。
Korean J Radiol. 2023 Jul;24(7):668-680. doi: 10.3348/kjr.2022.1022.
2
Radiomic Machine Learning and External Validation Based on 3.0 T mpMRI for Prediction of Intraductal Carcinoma of Prostate With Different Proportion.基于3.0 T磁共振多参数成像的影像组学机器学习及外部验证对不同比例前列腺导管内癌的预测
Front Oncol. 2022 Jun 28;12:934291. doi: 10.3389/fonc.2022.934291. eCollection 2022.
3
Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.联合临床参数和多参数磁共振成像预测前列腺外疾病-用于计划根治性前列腺切除术时患者个体化风险分层的风险模型。
Eur Urol Focus. 2020 Nov 15;6(6):1205-1212. doi: 10.1016/j.euf.2018.11.004. Epub 2018 Nov 23.
4
Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers.前列腺管内癌(IDC-P)降低了中等风险前列腺癌的表观扩散系数(ADC)值。
J Magn Reson Imaging. 2019 Jul;50(1):279-287. doi: 10.1002/jmri.26594. Epub 2018 Dec 25.
5
Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.多参数磁共振成像对临床列线图预测前列腺癌不良病理的增值作用。
J Urol. 2018 Nov;200(5):1041-1047. doi: 10.1016/j.juro.2018.05.094. Epub 2018 May 29.
6
Which one is better for predicting extraprostatic extension on multiparametric MRI: ESUR score, Likert scale, tumor contact length, or EPE grade?在多参数 MRI 上,哪种方法更能预测前列腺外延伸:ESUR 评分、Likert 量表、肿瘤接触长度还是 EPE 分级?
Eur J Radiol. 2022 Apr;149:110228. doi: 10.1016/j.ejrad.2022.110228. Epub 2022 Feb 23.
7
Multiparametric MRI-based radiomics nomogram for preoperative prediction of lymphovascular invasion and clinical outcomes in patients with breast invasive ductal carcinoma.基于多参数 MRI 的放射组学列线图预测乳腺浸润性导管癌患者的脉管侵犯和临床结局。
Eur Radiol. 2022 Jun;32(6):4079-4089. doi: 10.1007/s00330-021-08504-6. Epub 2022 Jan 20.
8
Cribriform architecture prostatic adenocarcinoma in needle biopsies is a strong independent predictor for lymph node metastases in radical prostatectomy.针吸活检中筛状结构前列腺腺癌是根治性前列腺切除术中淋巴结转移的有力独立预测指标。
Eur J Cancer. 2021 May;148:432-439. doi: 10.1016/j.ejca.2020.09.016. Epub 2020 Oct 16.
9
Head-to-head comparison between multiparametric MRI, the partin tables, memorial sloan kettering cancer center nomogram, and CAPRA score in predicting extraprostatic cancer in patients undergoing radical prostatectomy.多参数 MRI、Partin 表、纪念斯隆-凯特琳癌症中心列线图和 CAPRA 评分在预测接受根治性前列腺切除术患者前列腺外癌中的头对头比较。
J Magn Reson Imaging. 2019 Nov;50(5):1604-1613. doi: 10.1002/jmri.26743. Epub 2019 Apr 7.
10
Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection.基于筛状和管内癌的预测价值为前列腺癌患者盆腔淋巴结清扫术的列线图选择。
Urology. 2022 Oct;168:156-164. doi: 10.1016/j.urology.2022.04.043. Epub 2022 Jul 5.

本文引用的文献

1
Sensitivity of multiparametric MRI and targeted biopsy for detection of adverse pathologies (Cribriform gleason pattern 4 and intraductal carcinoma): Correlation of detected and missed prostate cancer foci with whole mount histopathology.多参数 MRI 和靶向活检检测不良病理(筛状格里森 4 级和导管内癌)的敏感性:全切除组织病理学检测到和漏诊的前列腺癌病灶的相关性。
Urol Oncol. 2022 Oct;40(10):452.e1-452.e8. doi: 10.1016/j.urolonc.2022.07.012. Epub 2022 Aug 23.
2
Defining Diagnostic Criteria for Prostatic Ductal Adenocarcinoma at Multiparametric MRI.前列腺导管腺癌的多参数 MRI 诊断标准定义。
Radiology. 2022 Apr;303(1):110-118. doi: 10.1148/radiol.204732. Epub 2022 Jan 25.
3
MRI-detectability and histological factors of prostate cancer including intraductal carcinoma and cribriform pattern.
MRI 检测能力与前列腺癌的组织学因素,包括导管内癌和筛状模式。
Prostate. 2022 Mar;82(4):452-463. doi: 10.1002/pros.24291. Epub 2021 Dec 28.
4
The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first-line therapy for patients with metastatic castration-resistant prostate cancer.前列腺管内癌的异质性与转移性去势抵抗性前列腺癌患者标准一线治疗的不同疗效相关。
Prostate. 2021 Nov;81(15):1191-1201. doi: 10.1002/pros.24215. Epub 2021 Aug 26.
5
A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging.一种用于预测前列腺癌患者淋巴结侵犯的新型列线图:多参数磁共振成像中囊外扩展的重要性。
Urol Oncol. 2021 Jul;39(7):431.e15-431.e22. doi: 10.1016/j.urolonc.2020.11.040. Epub 2021 Jan 8.
6
Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives.前列腺导管内癌:发病机制和分子观点。
Eur Urol Focus. 2021 Sep;7(5):955-963. doi: 10.1016/j.euf.2020.10.007. Epub 2020 Oct 31.
7
Normalized apparent diffusion coefficient: a novel paradigm for characterization of endometrial and subendometrial lesions.标准化表观扩散系数:一种用于描述子宫内膜和子宫内病变的新方法。
Br J Radiol. 2021 Jan 1;94(1117):20201069. doi: 10.1259/bjr.20201069. Epub 2020 Nov 6.
8
Intraductal carcinoma of the prostate in an Irish prostate cancer patient cohort-an aggressive pathology and a strong familial link.爱尔兰前列腺癌患者队列中的前列腺导管内癌——一种侵袭性病理及紧密的家族关联。
Prostate Int. 2020 Sep;8(3):107-111. doi: 10.1016/j.prnil.2020.02.001. Epub 2020 Feb 25.
9
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.2019 年国际泌尿病理学会(ISUP)前列腺癌分级共识会议。
Am J Surg Pathol. 2020 Aug;44(8):e87-e99. doi: 10.1097/PAS.0000000000001497.
10
Extraprostatic extension in prostate cancer: primer for radiologists.前列腺癌的前列腺外延伸:放射科医生入门。
Abdom Radiol (NY). 2020 Dec;45(12):4040-4051. doi: 10.1007/s00261-020-02555-x.